Bayer executive: US tariffs will not affect the company’s 2026 performance forecast

格隆汇2026/04/08 07:28

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Glonghui, April 8｜Sebastian Guth, Chief Operating Officer and President of Bayer US, stated that there is no need to adjust the 2026 forecast due to the US government’s announcement last week of tariffs on imported pharmaceuticals. He mentioned that the US has already committed to abiding by a trade agreement signed with the EU last year, which sets a maximum tariff of 15% on most goods from the EU (including pharmaceuticals). In March this year, Bayer forecasted earnings before interest, taxes, depreciation and amortization (EBITDA) excluding special items for 2026 to be between 9.6 billion and 10.1 billion euros, while EBITDA excluding special items for 2025 is expected to be 9.669 billion euros.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Duan Yongping has made it clear that he will not sell Nvidia and sold a large number of put options on the day the news was released. Nvidia may invite Jensen Huang to serve as an advisor, taking on a “shadow CEO” role to retain his influence, but he would no longer have signing authority. Whether this scenario materializes will likely only become clear after the hearing concludes.

华尔街见闻•2026/11/13 07:48